Inflammatory bowel disease in the elderly

Paul E. Evans, Darrell S. Pardi

Research output: Contribution to journalReview article

6 Scopus citations

Abstract

The incidence of inflammatory bowel disease in patients aged 60 years and older is approximately 3.5/100,000 people/year for Crohn's disease and 4.5/100,000 people/year for ulcerative colitis. An increased frequency of comorbidities and an increased risk of other forms of colitis in elderly patients can make the diagnosis of inflammatory bowel disease challenging. The clinical course of inflammatory bowel disease in the elderly is generally similar to that in younger patients, with primary differences noted in symptom frequency and disease location. The treatment of inflammatory bowel disease in the elderly is also generally the same as that for younger patients. Elderly patients are more likely to experience side-effects from corticosteroids and to have contraindications to immunosuppressive therapy. Surgical outcomes for inflammatory bowel disease in the elderly patient have improved over time. Outcomes and complications from surgery in the elderly population are similar to those of younger patients.

Original languageEnglish (US)
Pages (from-to)77-84
Number of pages8
JournalAging Health
Volume3
Issue number1
DOIs
StatePublished - Feb 1 2007

Keywords

  • 6-mercaptopurine
  • Azathioprine
  • Budesonide
  • Corticosteroid
  • Crohn's disease
  • Cyclosporine
  • Diagnosis
  • Elderly
  • Epidemiology
  • Inflammatory bowel disease
  • Infliximab
  • Mesalamine
  • Methotrexate
  • Sulfasalazine
  • Treatment
  • Ulcerative colitis

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Fingerprint Dive into the research topics of 'Inflammatory bowel disease in the elderly'. Together they form a unique fingerprint.

  • Cite this